Industryweek 6748 Pradaxa1

Boehringer Ingelheim Pays $650 Million in Pradaxa Lawsuits

May 28, 2014
The drug has been blamed for more than 500 deaths caused by uncontrolled bleeding.

FRANKFURT -- Pharmaceuticals maker Boehringer Ingelheim said Wednesday it has agreed to pay $650 million to settle around 4,000 lawsuits relating to its blood-thinning drug Pradaxa.

"Boehringer Ingelheim announced today that the company has reached a comprehensive settlement of state and federal cases in the U.S. litigation regarding Pradaxa," the company said.

Boehringer Ingelheim insisted that it continued to stand behind the drug, which is used to prevent blood clots and stroke by thinning the blood.

But Pradaxa has been blamed for more than 500 deaths caused by uncontrolled bleeding.

The German group insisted that the US Food and Drug Administration has reaffirmed the "positive benefit-risk profile of Pradaxa."

"The settlement enables Boehringer Ingelheim to focus solely on its mission of improving patients' lives and allows the company to avoid the distraction and uncertainty of lengthy litigation," the statement said.

The company said there were approximately 4,000 claims that it was seeking to resolve with this settlement.

"Boehringer Ingelheim expects most, if not all, of the plaintiffs to accept the terms of the settlement and Boehringer Ingelheim will vigorously defend against those who do not," the statement said.

"Notwithstanding our strong belief that we would prevail in these lawsuits, this settlement allows our company to avoid the distraction and uncertainty of protracted litigation over years and years," said the company's legal chief, Andreas Neumann.

Copyright Agence France-Presse, 2014

Continue Reading

Popular Sponsored Recommendations

The Benefits of Continuous Thermal Monitoring

Oct. 17, 2023
Read this eBook to learn more about collecting and using data intelligently to improve performance.

Beware Extreme Software

Sept. 24, 2023
As a manufacturer, you understand the importance of staying ahead of the curve and being proactive in your approach to technology. With the rapid pace of change in the industry...

How Digital Twin Technology is Empowering Manufacturers

Sept. 27, 2023
This FAQ delves into why this technology offers business value and considerations toward implementation.

Food and Beverage 2024 Trends and Outlook for North America

Oct. 29, 2023
Ready to hear what 200 of your peers said are the top challenges and opportunities in 2024? Don’t fall behind. Uncover actionable insights to better prepare for 2024 in this whitepaper...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!